| Anderson (formerly Broder), Elizabeth (LianBio 202103 VP Communications + IR before MeiraGTx) |
Public Relations Manager / Investor Relations Manager |
LianBio |
|
| Crawford-Brunt, Andre (Braavos Investment Advisors 202102 General Partner) |
Board member, non-executive |
Braavos Investment Advisers |
|
| Earl, Michael (Celtic Pharma 201301 + Pro Bono Bio 201209 COO) |
Partner (venture partner) |
Auven Therapeutics (Group) |
|
| Fry, Nigel (Schauenburg 202309– CEO of Schauenburg Analytics Group before Antylia Scientific + GE Healthcare) |
Chief Executive Officer (CEO) |
Schauenburg (Group) |
|
| Inde, Karsten (Team Olivia 201909 Founder) |
Company Founder |
|
|
| Jonsson, Ulf (Biacore founder 1996 + CEO 2000–2004 before Pharmacia Biosensor AB before Pharmacia Fine Chemicals) |
Chief Executive Officer (CEO) |
General Electric (Group) |
|
| Knowles, Tuomas (Fluidic Analytics 201809 CSO + Professor at Univ Cambridge) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Fluidic Analytics Ltd. |
|
| Laustsen, Andreas (VenomAB 201610 CEO + Founder + Biosyntia + Antag) |
Chief Executive Officer (CEO) |
|
|
| Lee, Michael (Syngenta 201809 Director at Syngenta Ventures) |
Investment Manager |
Syngenta (Group) |
|
| Sullivan, Kevin (Principal Forensic Services 201510 Director before at UK Forensic Science Service) |
Consultant (economic/technology) |
Principal Forensic Services |
|
| Turner, Diane |
n. a. |
|
|
| Uhlén, Mathias (Royal Institute of Technology (SE) 201509 Professor of Microbiology) |
Professor |
|
|
| White, Bryan |
n. a. |
|
|
| Winkler, Frank (Univ Heidelberg + DKFZ 201909 Professor + Co-Founder of Divide & Conquer) |
Professor |
University of Heidelberg (Ruperto Carola) |
|
| Xu, Joanne (SoftBank 202106 Partner at SoftBank Investment Advisers + 202106– Board Director at Exscientia) |
Partner (venture partner) |
SoftBank (Group) |
|
| Chiplin, John (Peptech 200601– CEO before Newstar Ventures before ITI Life Sciences before Geneformatics) |
Chief Executive Officer (CEO) |
Arana Therapeutics (Group) |
Australia |
| Jump, Colin (Dawes Scientific 201602– CEO at ETP before Microsaic CEO + Managing Director Shimadzu UK + SGE Europe) |
Managing Director |
Dawes Scientific (Group) |
Australia |
| Nicholson, Jeremy (Murdoch Univ + ANPC 201909 Prof before Imperial College + MRC-NIHR Phenome Centre) |
Professor |
Murdoch University |
Australia |
| Thompson, Stephen (Brandon Capital 202011 formerly at Apax Partners) |
Investment Manager |
Brandon Capital Partners (AU) |
Australia |
| Tobin, Jonathan (Brandon Capital 202209 Partner before Arix Bioscience 201706) |
Investment Manager |
Brandon Capital Partners (AU) |
Australia |
| FitzGerald, Kevin (Activiomics 201304– CEO F-Star 201104–201205 CEO LEFT 5/12 + Isogenica + CAT) |
Chief Executive Officer (CEO) |
Sino Biopharm (Group) |
Austria |
| Kerschbaumer, Randolf (OncoOne 202003 CEO + Co-Founder before Shire + Baxter BioScience) |
Chief Executive Officer (CEO) |
OncoOne Research & Development GmbH |
Austria |
| Müllner, Markus (Celeris Therapeutics 202202– VP of Biology before PhoreMost) |
Research & Development Manager |
Celeris Therapeutics (CelerixTx) (Group) |
Austria |
| Scheiflinger, Friedrich (Fritz) (Evotec 202004 EVP Head Gene Therapy before Shire/Takeda 201707 Head Global Research) |
President/Director/Head Business Group/Unit/Division |
Evotec Gene Therapy (Orth, AT, Evotec GT) |
Austria |
| Boucher, Oliver (Bioxodes 201311 Executive Director before CBO at Vivacta + Sigmoid Pharma + Trigen) |
Business Development Manager / Strategy Manager |
Bioxodes S.A. |
Belgium |
| Forte, Miguel (Bone Therapeutics 202001– CEO before Zelluna + Bone Therapeutics + TxCell + UCB + Nabi + BMS + EMA) |
Chief Executive Officer (CEO) |
Bone Therapeutics (Group) |
Belgium |
| Francis, Nick (fomerly M:Communications 201104) |
Public Relations Manager / Investor Relations Manager |
UCB (Group) |
Belgium |
| Gilham, David (Celyad 201609– VP RnD before Univ Manchester MCRC + Bristol Univ) |
Research & Development Manager |
Celyad (Group) |
Belgium |
| Harmeier, Anja (Rewind Therapeutics 202301 CEO + Bellevue 202007 Partner at Pureos Bioventures) |
Chief Executive Officer (CEO) |
Rewind Therapeutics N.V. |
Belgium |
| Hassan, Tolga (AgomAb Therapeutics 202103– CFO before F-Star + Johnson Matthey) |
Chief Financial Officer (CFO) |
Agomab Therapeutics (Group) |
Belgium |
| Powell, Steven (eTheRNA CEO 202006 before Macrophage Pharma 201705 CEO) |
Chief Executive Officer (CEO) |
eTheRNA (Group) |
Belgium |
| Schneider, Susan (ThromboGenics 201711– CMO before Allergan) |
Chief Medical Officer (CMO) |
Oxurion (Group) |
Belgium |
| Theoharis, Stefanos (Bone Therapeutics 202003– CBO before Cell Medica + Apceth + Antisense Pharma + Roche + Lazard) |
Chief Business Officer (CBO) |
Bone Therapeutics (Group) |
Belgium |
| Thys, Hendrik (Ziphius Vaccines 202105 IR Manager formerly Consilium Strategic Communications 201602) |
Public Relations Manager / Investor Relations Manager |
Ziphius Vaccines N.V. |
Belgium |
| Vlemmix, Michaël (Gimv 202011) |
Principal (venture capital) |
Gimv (Group) |
Belgium |
| D’Andrea, Larry (Spartan Bioscience 200909– CEO before Grant Thornton LLP Canada) |
Chief Executive Officer (CEO) |
Spartan Bioscience Inc. |
Canada |
| Bisgaard, Peter (Nan Fung 202108 Managing Director of NFLS + Pivotal Life Sciences before Novo) |
Managing Director |
Nan Fung (Group) |
China |
| Grant, Angus (BeiGene 202007– Chief Business Executive before Dementia Discovery Fund + Celgene) |
Chief Executive Officer (CEO) |
BeiGene (Group) |
China |
| Kaminskiy, Dmitry (Digital Knowledge Ventures 202112 General Partner + Founder) |
General Partner (venture partner) |
Deep Knowledge Ventures (Deep Knowledge Group, DKG) (Group) |
China |
| Li, Min (SciNeuro 202303 CEO + Founder formerly GSK 201604 SVP + Global Head of Neurosciences) |
Chief Executive Officer (CEO) |
SciNeuro (Group) |
China |
| Vadlamudi, Sree (MindRank AI formerly e-Therapeutics 201808 Business Development + Programme Manager) |
Business Development Manager / Strategy Manager |
MindRank (Group) |
China |
| Wang, Zilong (Allen) (HEL Group 202302– promoted to General Manager of H.E.L. China before Malvern Pananalytical) |
General Manager (management) |
HEL (H.E.L.) (Group) |
China |
| Zhou, Jason (China Resources Group 202008 CEO + Managing Director of CR-CP Life Science Fund) |
Chief Executive Officer (CEO) |
China Resources Group (Group) |
China |
| Zou, Johnny (Primavera Capital 202109 at Primavera Venture Partners) |
Investment Manager |
Primavera Capital (Group) |
China |
| Dudfield, Phil (Galapagos 201301– Head of new Fidelta division before BioFocus DPI 200709 VP Discovery Products) |
President/Director/Head Business Group/Unit/Division |
Selvita (Group) |
Croatia |
| Aabo, Gitte (Leo Pharma 201511 CEO) |
Chief Executive Officer (CEO) |
Leo Pharma (Group) |
Denmark |
| Aamund, Asger (Bavarian Nordic 200804 Chairman) |
n. a. |
Bavarian Nordic (Group) |
Denmark |
| Absalonsen, Karin (Hannibal Innovation 202310) |
n. a. |
Hannibal Innovation ApS |
Denmark |
| Acosta, Colleen (Freya Biosciences 20231212 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Freya Biosciences ApS |
Denmark |
| Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) |
Managing Partner (investment firm) |
Lundbeck (Group) |
Denmark |
| Albinus, Bjørn (Cheminova 200504 Managing Director) |
Managing Director |
Auriga Industries (Group) |
Denmark |
| Albrechtsen, Morten (Nanovi ApS 201311 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Nanovi A/S |
Denmark |
| Alsbo, Carsten (Exiqon 200904 Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Denmark |
| Álvarez-Martos, Isabel (Cellugy 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellugy (DK) |
Denmark |
| Ameri, Jacqueline (Pancryos 202205 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Pancryos ApS |
Denmark |
| Andersson, Ann-Sofie (Copenhagen (govt) 201701 Business Development Manager Life Sciences at Copenhagen Capacity) |
Business Development Manager / Strategy Manager |
Copenhagen (govt region) |
Denmark |
| Andersson, Claus A. (Sunstone Capital 201511 Partner Life Sciences) |
Partner (venture partner) |
Sunstone Life Science (Group) |
Denmark |
| Andersson, Poul (DTU 201404 CEO of Bioneer A/S) |
Chief Executive Officer (CEO) |
Technical University of Denmark (DTU) |
Denmark |
| Andreu, Fernando (2curex 202101– before Indivumed + Sysmex Inostics) |
Chief Executive Officer (CEO) |
2cureX (Group) |
Denmark |
| Auster, Martin (Ascendis Pharma 201406– CBO before United Therapeutics as VP Business Development) |
Chief Business Officer (CBO) |
Ascendis Pharma (Group) |
Denmark |
| Bache, Nicolai (Evosep 201803 Head of Applications) |
Technical Manager |
Evosep ApS |
Denmark |
| Baiget, Ester (Novozymes 202212 CEO) |
Chief Executive Officer (CEO) |
Novozymes (Group) |
Denmark |
| Baker, Melinda (Ascendis Pharma 202108– Senior Director Coroporate Communications before Zogenix) |
Public Relations Manager / Investor Relations Manager |
Ascendis Pharma (Group) |
Denmark |
| Bakker, Jeroen (Novo Group 202010 at Novo Seeds) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Bech Jensen, Ejner (Agrobiomics 202309 CEO before Novozymes 201112 VP RnD) |
Chief Executive Officer (CEO) |
Agrobiomics (DK) |
Denmark |
| Benediktsson, Jón Ingi (SEED Capital 201108 Investment Manager) |
Investment Manager |
SEED Capital Denmark (SEED Capital Management I/S) |
Denmark |
| Bennett, Eric Paul (Cobo Technologies 201907 Scientific Advisor + Co-Founder) |
Consultant (economic/technology) |
Cobo Technologies (Group) |
Denmark |
| Benson, Peter (Sunstone Capital 200705– Managing Partner Life Science Ventures) |
Managing Partner (investment firm) |
Sunstone Life Science (Group) |
Denmark |
| Berkien, Ton (Nuevolution 201401– CBO before Takeda/Nycomed + Ferring + PricewaterhouseCoopers) |
Chief Business Officer (CBO) |
Nuevolution (Group) |
Denmark |
| Bern, Morten (Evosep 202309– promoted to CEO joined recently as CCO before Thermo Fisher) |
General Manager (management) |
Evosep ApS |
Denmark |
| Binné, Ulrich (Freya Biosciences 202312 CBO + Co-Founder) |
Chief Business Officer (CBO) |
Freya Biosciences ApS |
Denmark |
| Birk, Henrik (Bavarian Nordic 201701– COO joined in 2008 before Coloplast) |
Chief Operating Officer (COO) |
Bavarian Nordic (Group) |
Denmark |
| Blou, Henrik (Gubra ApS 201709 CEO before EpiTherapeutics ApS 201304 Business Development Director) |
Chief Executive Officer (CEO) |
Gubra ApS |
Denmark |
| Bock, Jens-Ole (Cobo Technologies 201907 CEO + Co-Founder before Sigma-Aldrich) |
Chief Executive Officer (CEO) |
Cobo Technologies (Group) |
Denmark |
| Bodekaer Jensen, Michael (Labster 202204 CEO + Co-Founder) |
Board member, executive |
Labster (Group) |
Denmark |
| Bogeso, Klaus Peter (Lundbeck 200607 VP) |
n. a. |
Lundbeck (Group) |
Denmark |
| Bonde, Mads Tvillinggaard (Labster 202204 Executive Chairman + Co-Founder) |
Board member, executive |
Labster (Group) |
Denmark |
| Borodina, Irina (BioPhero 201809– Research Director before CEO + Founder) |
Research & Development Manager |
FMC (Group) |
Denmark |
| Bourdon, Christophe (Leo Pharma 202204– CEO before Orphazyme + Amgen + Alexion) |
Managing Director |
Leo Pharma (Group) |
Denmark |
| Boysen, Jesper (Nanovi 201908 CEO) |
Chief Executive Officer (CEO) |
Nanovi A/S |
Denmark |
| Braestrup, Claus (Bavarian Nordic 200804 Managing Director before Lundbeck CEO) |
Managing Director |
Bavarian Nordic (Group) |
Denmark |
| Bramming, Jesper (Symphogen 201609– CFO before CMC Biologics + Nets Holdings + A.P: Møller-Maersk Group + Svitzer) |
Chief Financial Officer (CFO) |
Servier (Group) |
Denmark |
| Brandgaard, Jesper (Novo 201609 CFO of Novo Nordisk) |
Chief Financial Officer (CFO) |
Novo Group (Group) |
Denmark |
| Brennan, Dan (NMD Pharma 202311 SVP Corporate + Commercial Strategy) |
Business Development Manager / Strategy Manager |
NMD Pharma A/S |
Denmark |
| Brinkmann, Thomas (Unilabs 201306 CMO) |
Chief Medical Officer (CMO) |
Unilabs (Group) |
Denmark |
| Brodersen, Hamed (Hannibal Innovation 202310 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Hannibal Innovation ApS |
Denmark |
| Brookes, Graeme (Reapplix 202007 CEO) |
Chief Executive Officer (CEO) |
Reapplix (Group) |
Denmark |
| Bryderup, Eva (Evosep 202309 Marcom Manager) |
Public Relations Manager / Investor Relations Manager |
Evosep ApS |
Denmark |
| Buch Pedersen, Morten Jeppe (Pcovery 201107 CEO) |
Chief Executive Officer (CEO) |
Pcovery ApS |
Denmark |
| Buhl Jensen, Peter (Univ Copenhagen 201112 Prof + CEO LiPlaseom Pharma before Topotarget Co-founder + CEO 2001–2010) |
Professor |
University of Copenhagen |
Denmark |
| Busch-Larsen, Henrik (Unibio 201908 CEO) |
Chief Executive Officer (CEO) |
Unibio (Group) |
Denmark |
| Bülow-Nielsen, Tonni (Denmark (govt) 202301 Partner at EIFO) |
Principal (venture capital) |
Denmark (govt) |
Denmark |
| Capparelli, Clara (Cellugy 202101 Media + Communications Coordinator) |
Public Relations Manager / Investor Relations Manager |
Cellugy (DK) |
Denmark |
| Carlsen, Andrew (Genmab 201907 Senior Director IR) |
Public Relations Manager / Investor Relations Manager |
Genmab (Group) |
Denmark |
| Carlsen, Søren (Novo Group 201505 Managing Partner of Novo Ventures + Novo Seeds) |
Managing Partner (investment firm) |
Novo Group (Group) |
Denmark |
| Carlsson, Carl-Ake (Novo Group 201305 CEO of Xellia Pharmaceuticals) |
Chief Executive Officer (CEO) |
Novo Group (Group) |
Denmark |
| Chakel, John (Proxeon 200711– VP BusDev North America before Agilent) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Denmark |
| Chaplin, Paul (Bavarian Nordic 201410 CEO) |
Chief Executive Officer (CEO) |
Bavarian Nordic (Group) |
Denmark |
| Chenoweth, Dennis (DakoCytomation 200506 Coporate VP Strategic Business Pathology) |
Business Development Manager / Strategy Manager |
Agilent (Group) |
Denmark |
| Chrintz, Ole (Lundbeck 201304 SVP International Markets + Europe) |
President/Director/Head Business Group/Unit/Division |
Lundbeck (Group) |
Denmark |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
